The ratings of 3 Life Sciences Tools & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Slipping from a C to a D rating, PAREXEL International Corporation (PRXL) takes a hit this week. PAREXEL International Corporation is a contract research and product launch organization. For more information, get Portfolio Grader’s complete analysis of PRXL stock.
pSivida Corp. (PSDV) gets weaker ratings this week as last week’s C drops to a D. PSivida Corp. develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection, or insertion. The company also gets F’s in operating margin growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of PSDV stock.
Bioanalytical Systems, Inc. (BASI) slips from a D to a F this week. Bioanalytical Systems, Inc. provides contract drug development services and research equipment to many global pharmaceutical, medical research and biotechnology companies and institutions. The company also gets F’s in sales growth, operating margin growth, earnings growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of BASI stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.